专家论坛·心力衰竭诊治新进展
心脏瓣膜病治疗:经导管瓣膜治疗的适应人群
——2020年ACC/AHA瓣膜病管理指南解读和思考
······························································································· 杜 俣,刘 巍,周玉杰
心力衰竭合并左束支传导阻滞的病理生理机制及心脏磁共振分析
··············································································································· 常三帅,董建增
沙库巴曲缬沙坦在射血分数保留心力衰竭患者中的临床研究进展
······························································································· 王 红,娄 奇,李为民
心脏磁共振在心力衰竭病因分析中的应用
··············································································································· 杨映霞,陆敏杰
钠-葡萄糖共转运蛋白2抑制剂治疗心力衰竭循证证据与机制的研究进展
······························································································· 梁志山,许志盟,吉庆伟
心脏再同步治疗与希浦氏起搏在慢性心衰合并完全性左束支传导阻滞中的应用进展
······························································································· 陆政德,石 磊,胡昌兴